May 7, 2020 / 11:51 AM / 25 days ago

BRIEF-Amicus Therapeutics Announces First Quarter 2020 Financial Results

May 7 (Reuters) - Amicus Therapeutics Inc:

* AMICUS THERAPEUTICS ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS AND CORPORATE UPDATES

* SEES FY 2020 REVENUE $250 MILLION TO $260 MILLION

* Q1 EARNINGS PER SHARE ESTIMATE $-0.28 — REFINITIV IBES DATA

* AMICUS THERAPEUTICS - TOTAL REVENUE IN Q1 2020 WAS $60.5 MILLION, A YEAR-OVER-YEAR INCREASE OF 78%

* SEES NON-GAAP OPERATING EXPENSE GUIDANCE FOR FULL-YEAR 2020 $410 MILLION TO $420 MILLION

* Q1 REVENUE VIEW $57.5 MILLION — REFINITIV IBES DATA

* FY2020 REVENUE VIEW $257.1 MILLION — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below